ELISA BCL2L1 anti-

Quantity :50µL Clone Number:5E9 Aliases:Bcl-2-like protein 1 (Bcl2-L-1) (Apoptosis regµLator Bcl-X), BCL2L1, BCL2L BCLX Product Type:Recombinant Antibody Immunogen Species:Homo sapiens () UniProt ID:Q07817 Immunogen:A syntheQuantityd peptide derived from Bcl-XL Raised in: Reactivity:, Mouse, Rat Tested Applications:ELISA, WB, IHC; Recommended dilution: WB:1:500-1:5000, IHC:1:50-1:200 Background:Potent inhibitor of cell death. Inhibits activation of caspases. Appears to regµLate cell death by blocking the voltage-dependent anion channel (VDAC) by binding to it and preventing the release of the caspase activator, CYC1, from the mitochondrial membrane. Also acts as a regµLator of G2 checkpoint and progression to cytokinesis during mitosis. Clonality:Monoclonal Isotype:Rabbit IgG Purification Method:Affinity-chromatography Conjµgate:Non-conjµgated Buffer:Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Form:Liquid Stroage:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. Target Names:BCL2L1 Research Areas:Cancer; Cell biology; Metabolism; Signal transduction